Predictive Progression Outcomes and Risk Stratification in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Who Received First-Line Immunochemotherapy
CLINICAL & TRANSLATIONAL ONCOLOGY(2024)
Key words
Recurrent or metastatic nasopharyngeal carcinoma,First-line immunochemotherapy,Acquired resistance,Progression,Nomogram
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined